{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:19:56Z","timestamp":1780384796891,"version":"3.54.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ccm.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T10:11:28Z","timestamp":1470737488000},"page":"389-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"37","author":[{"given":"Simon R.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo M.","family":"Taveira-DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2016.04.002_bib1","first-page":"971","article-title":"Regional and National variability suggests underestimation of prevalence of lymphangioleiomyomatosis","volume":"104","author":"Harknett","year":"2011","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1164\/ajrccm.162.2.9911006","article-title":"Pulmonary lymphangioleiomyomatosis in a man","volume":"162","author":"Aubry","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.crad.2011.02.009","article-title":"Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex","volume":"66","author":"Adriaensen","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ccm.2016.04.002_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.200610-1408CR","article-title":"Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex","volume":"176","author":"Schiavina","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J\u00a0Nippon Med Sch"},{"key":"10.1016\/j.ccm.2016.04.002_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000478-200104000-00007","article-title":"Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score","volume":"25","author":"Matsui","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib7","first-page":"348","article-title":"Pulmonary lymphangioleiomyomatosis","volume":"79","author":"Corrin","year":"1975","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib8","first-page":"977","article-title":"Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations","volume":"116","author":"Carrington","year":"1977","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.ccm.2016.04.002_bib9","doi-asserted-by":"crossref","first-page":"e0126025","DOI":"10.1371\/journal.pone.0126025","article-title":"Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis","volume":"10","author":"Clements","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2016.04.002_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1165\/rcmb.2014-0224OC","article-title":"Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis","volume":"53","author":"Atochina-Vasserman","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/01.pas.0000126859.70814.6d","article-title":"Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis","volume":"28","author":"Kumasaka","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000325340","article-title":"Cytologic, immunocytochemical and ultrastructural characterization of lymphangioleiomyomatosis cell clusters in chylous effusions of patients with lymphangioleiomyomatosis","volume":"53","author":"Mitani","year":"2009","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ccm.2016.04.002_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1148\/radiol.2421051767","article-title":"Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features","volume":"242","author":"Avila","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.ccm.2016.04.002_bib14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/hupa.2000.18500","article-title":"Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases","volume":"31","author":"Matsui","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1148\/radiology.216.1.r00jl42147","article-title":"Lymphangioleiomyomatosis: abdominopelvic CT and US findings","volume":"216","author":"Avila","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.ccm.2016.04.002_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.161.3.9904009","article-title":"Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study","volume":"161","author":"Matsui","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib17","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.1309110110","article-title":"Integration of mTOR and estrogen\u2013ERK2 signaling in lymphangioleiomyomatosis pathogenesis","volume":"110","author":"Gu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ccm.2016.04.002_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","article-title":"Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene","volume":"182","author":"Pacheco-Rodriguez","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ccm.2016.04.002_bib19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.4049\/jimmunol.0902149","article-title":"Role of the\u00a0CXCR4\/CXCL12 Axis in lymphangioleiomyomatosis and angiomyolipoma","volume":"185","author":"Clements","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ccm.2016.04.002_bib20","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1158\/0008-5472.CAN-07-1356","article-title":"TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis","volume":"67","author":"Pacheco-Rodriguez","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ccm.2016.04.002_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2005-0387OC","article-title":"Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis","volume":"35","author":"Valencia","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1465-9921-13-34","article-title":"Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis","volume":"13","author":"Chang","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2016.04.002_bib23","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.00095.2010","article-title":"Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2","volume":"300","author":"Ikeda","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ccm.2016.04.002_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib25","first-page":"687","article-title":"Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases","volume":"78","author":"Fukuda","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.ccm.2016.04.002_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of\u00a0pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1165\/rcmb.2002-0124OC","article-title":"Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression","volume":"28","author":"Zhe","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rmed.2008.07.017","article-title":"Matrix metalloproteinases in blood from patients with LAM","volume":"103","author":"Odajima","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jaad.2004.01.055","article-title":"Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis","volume":"51","author":"Papakonstantinou","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.ccm.2016.04.002_bib30","first-page":"106","article-title":"Lymphatic manifestations of lymphangioleiomyomatosis","volume":"47","author":"Gupta","year":"2014","journal-title":"Lymphology"},{"key":"10.1016\/j.ccm.2016.04.002_bib31","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis - a wolf in sheep\u2019s clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccm.2016.04.002_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.2008.189","article-title":"Cathepsin-k expression in pulmonary lymphangioleiomyomatosis","volume":"22","author":"Chilosi","year":"2009","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.ccm.2016.04.002_bib33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"50","key":"10.1016\/j.ccm.2016.04.002_bib34","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ccm.2016.04.002_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201003-0489OC","article-title":"Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis","volume":"182","author":"Cai","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201412-2170LE","article-title":"Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation","volume":"191","author":"Steagall","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib38","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib39","first-page":"3341","article-title":"Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosis","volume":"35","author":"Grzegorek","year":"2015","journal-title":"Anticancer Res"},{"issue":"12","key":"10.1016\/j.ccm.2016.04.002_bib40","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/PAS.0b013e318235edbd","article-title":"Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients","volume":"35","author":"Hayashi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib41","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ccm.2016.04.002_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mrrev.2008.01.001","article-title":"The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners","volume":"658","author":"Rosner","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.ccm.2016.04.002_bib44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a Novel Binding Partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Dos","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A\u00a0complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ccm.2016.04.002_bib46","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/MCB.01061-10","article-title":"mTORC2 is required for proliferation and survival of TSC2-Null cells","volume":"31","author":"Goncharova","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib48","doi-asserted-by":"crossref","unstructured":"Cordier JF, Johnson S. Multiple cystic lung disease. Orphan Lung Diseases. European Respiratory Monograph 2011. p. 46\u201383.","DOI":"10.1183\/1025448x.10007510"},{"key":"10.1016\/j.ccm.2016.04.002_bib49","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1183\/13993003.00570-2015","article-title":"Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases","volume":"46","author":"Gupta","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2016.04.002_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2016.04.002_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/lrb.2006.4.143","article-title":"Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis","volume":"4","author":"Seyama","year":"2006","journal-title":"Lymphatic Res Biol"},{"key":"10.1016\/j.ccm.2016.04.002_bib52","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.10-0573","article-title":"Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases","volume":"138","author":"Young","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1196\/annals.1413.018","article-title":"Lymphatic involvement in lymphangioleiomyomatosis","volume":"1131","author":"Glasgow","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ccm.2016.04.002_bib54","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"Zhe","year":"2004","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.ccm.2016.04.002_bib55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11684-012-0231-5","article-title":"Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis","volume":"6","author":"Meraj","year":"2012","journal-title":"Front Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib56","series-title":"Transbronchial lung biopsy in Lymphangioleiomyomatosis (LAM): diagnostic value and safety. A35. I've got a feeling we're going to solve this one: insights into lymphangioleiomyomatosis","first-page":"A1399","author":"Kai-Feng","year":"2015"},{"key":"10.1016\/j.ccm.2016.04.002_bib57","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/resp.12296","article-title":"Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy","volume":"19","author":"Fruchter","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2016.04.002_bib58","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/ajrccm.153.4.8616568","article-title":"Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity","volume":"153","author":"Crausman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib59","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200206-593OC","article-title":"Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis","volume":"168","author":"Taveira-DaSilva","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","article-title":"Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201cO\u201dP)","volume":"78","author":"Urban","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ccm.2016.04.002_bib62","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib63","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib64","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1183\/09031936.00167413","article-title":"A\u00a02-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis","volume":"43","author":"Chang","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2016.04.002_bib65","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2004.023283","article-title":"Survival and disease progression in UK patients with lymphangioleiomyomatosis","volume":"59","author":"Johnson","year":"2004","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.ccm.2016.04.002_bib66","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.ccm.2016.04.002_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-12-79","article-title":"\u201cGetting stuck with LAM\u201d: patients perspectives on living with Lymphangioleiomyomatosis","volume":"12","author":"Belkin","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ccm.2016.04.002_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/96.4.529","article-title":"Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung","volume":"96","author":"Ohori","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ccm.2016.04.002_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0020-7292(95)02619-3","article-title":"Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax","volume":"52","author":"Brunelli","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ccm.2016.04.002_bib71","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/thorax.57.12.1085","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment","volume":"57","author":"Yano","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2016.04.002_bib72","first-page":"199","article-title":"Pregnancy complicated with pulmonary lymphangioleiomyomatosis: case report","volume":"32","author":"Fujimoto","year":"2005","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ccm.2016.04.002_bib73","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/01443615.2013.812622","article-title":"Renal angiomyolipoma and lymphangioleiomyomatosis in pregnancy","volume":"33","author":"Iruloh","year":"2013","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ccm.2016.04.002_bib74","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1378\/chest.09-0624","article-title":"Reversible airflow obstruction in lymphangioleiomyomatosis","volume":"136","author":"Taveira-DaSilva","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib75","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-154-12-201106210-00008","article-title":"Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences","volume":"154","author":"Seibert","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib76","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ccm.2016.04.002_bib77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000059872","article-title":"The TSC2\/PKD1 contiguous gene syndrome","volume":"122","author":"Harris","year":"1997","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ccm.2016.04.002_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/ajrccm.164.6.2102125","article-title":"Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in Lymphangioleiomyomatosis","volume":"164","author":"Taveira-DaSilva","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib79","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ccm.2016.04.002_bib80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib81","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib82","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00210714","article-title":"Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study","volume":"46","author":"Goldberg","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2016.04.002_bib83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib84","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib85","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ccm.2016.04.002_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.resinv.2013.03.002","article-title":"The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis","volume":"51","author":"Ando","year":"2013","journal-title":"Respir Investig"},{"key":"10.1016\/j.ccm.2016.04.002_bib87","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jcph.428","article-title":"Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation","volume":"55","author":"Somers","year":"2015","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ccm.2016.04.002_bib88","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","article-title":"Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis","volume":"190","author":"Yao","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2016.04.002_bib89","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/thorax.55.12.1052","article-title":"Clinical experience of lymphangioleiomyomatosis in the UK","volume":"55","author":"Johnson","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2016.04.002_bib90","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","article-title":"Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications","volume":"129","author":"Almoosa","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib91","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1378\/chest.115.4.1041","article-title":"Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis","volume":"115","author":"Chu","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib92","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.123.2.623","article-title":"Chylothorax in\u00a0lymphangioleiomyomatosis","volume":"123","author":"Ryu","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-0031-1273941","article-title":"Thoracic duct embolization for chylous leaks","volume":"28","author":"Chen","year":"2011","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.ccm.2016.04.002_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13023-014-0151-3","article-title":"Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance","volume":"9","author":"Yeoh","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccm.2016.04.002_bib95","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ccm.2016.04.002_bib96","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1464-410X.2009.08649.x","article-title":"Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated","volume":"105","author":"Sooriakumaran","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ccm.2016.04.002_bib97","first-page":"836","article-title":"Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid","volume":"180","author":"Lane","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ccm.2016.04.002_bib98","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2016.04.002_bib99","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for Angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ccm.2016.04.002_bib100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ccm.2016.04.002_bib101","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1001\/jama.286.15.1879","article-title":"Meningiomas in lymphangioleiomyomatosis","volume":"286","author":"Moss","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2016.04.002_bib102","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/09031936.00093111","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients","volume":"40","author":"Cottin","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2016.04.002_bib103","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.07-0898","article-title":"Lymphangioleiomyomatosis: a clinical update","volume":"133","author":"McCormack","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2016.04.002_bib104","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJM199610243351704","article-title":"Lung transplantation for lymphangioleiomyomatosis","volume":"335","author":"Boehler","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2016.04.002_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2008.09.014","article-title":"Lung transplantation for lymphangioleiomyomatosis: the European experience","volume":"28","author":"Benden","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2016.04.002_bib106","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thx.2004.035154","article-title":"Emerging clinical picture of lymphangioleiomyomatosis","volume":"60","author":"Cohen","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2016.04.002_bib107","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.rmed.2003.11.013","article-title":"Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis","volume":"98","author":"Lazor","year":"2004","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.ccm.2016.04.002_bib108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jmg.2008.065342","article-title":"TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex","volume":"46","author":"Muzykewicz","year":"2009","journal-title":"J\u00a0Med Genet"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523116300399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523116300399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:53:25Z","timestamp":1759452805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523116300399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0272523116300399"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2016.04.002","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}